Investors in Theravance Biopharma (NASDAQ:TBPH) have unfortunately lost 52% over the last five years [Yahoo! Finance]
Theravance Biopharma, Inc. - Ordinary Shares (TBPH)
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.theravance.com/investor-relations
Company Research
Source: Yahoo! Finance
For example the Theravance Biopharma, Inc. NASDAQ:TBPH ) share price dropped 52% over five years. That's an unpleasant experience for long term holders. So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress. Check out our latest analysis for Theravance Biopharma Because Theravance Biopharma made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. When a company doesn't make profits, we'd generally hope to see good revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth. In the last five years Theravance Biopharma saw its revenue shrink by 6.4% per year. That's not what investors generally want to see. With neither profit nor revenue growth, the loss of 9% per year doesn't really surprise us. We don't think anyone is rushing to buy this stock. Not that many investors like to
Show less
Read more
Impact Snapshot
Event Time:
TBPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TBPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TBPH alerts
High impacting Theravance Biopharma, Inc. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
TBPH
News
- Theravance Biopharma, Inc. (NASDAQ: TBPH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Theravance Biopharma, Inc. (NASDAQ: TBPH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Methicillin-resistant Staphylococcus Aureus Drugs Market Research 2023-2024 & 2029 [Yahoo! Finance]Yahoo! Finance
- Theravance Biopharma, Inc. (NASDAQ: TBPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.MarketBeat
- Theravance Biopharma, Inc. (NASDAQ: TBPH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
TBPH
Earnings
- 5/13/24 - Beat
TBPH
Sec Filings
- 6/11/24 - Form SC
- 5/22/24 - Form 4
- 5/22/24 - Form 4
- TBPH's page on the SEC website